Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Mirexus Biotechnologies

Explore full profile

Mirexus – Safe & Natural Nanomaterials

Guelph, CanadaFounded 2008Consumer Services
Valuation $50–100M Last recorded · 2017
Headcount <100 Current team size
Total funding $10–50M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for Mirexus Biotechnologies and the history behind them.

About Mirexus Biotechnologies

Mirexus Inc. is a Canadian company specializing in the production of sustainable, plant-derived glycogen known as phytoglycogen, primarily for use in personal care and cosmetics products. This unique ingredient, discovered by researchers at the University of Guelph, is manufactured in Ontario from locally grown feedstock. Mirexus serves clients in the personal care and cosmetics industry, providing them with an innovative ingredient that enhances anti-aging and moisturizing properties in their products. The company operates in the global market, with a particular focus on sustainability and ethical business practices. Mirexus generates revenue by selling its phytoglycogen to manufacturers of skincare and cosmetic products who incorporate it into their formulations. The business model is centered around B2B sales, leveraging its unique product to differentiate itself in a competitive market. Mirexus is committed to minimizing its environmental impact and integrates sustainability into its operations. The company also actively participates in industry events, such as In-Cosmetics Asia, to showcase its products and expand its market reach.

Source: Dealroom company data

At a glance

Status
Operational
Founded
2008
Headquarters
Guelph, Canada
Employees
4
Open positions
None listed
Dealroom signal
50.3/100
Industry
Media, Chemicals
Sub-industry
Streaming
Sector
Consumer Services, Drones, Spinout, Nanomaterials, DT and LS, science-based
Technology
Deep Tech, Nanotech
Business model
Manufacturing
Client focus
b2b

Funding history

4 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
LATE VC✓Equity / VC Jun 2017 $12M $48M GreenSky Ventures · Goddard Enterprises —
SERIES A✓Equity / VC Oct 2015 $4.5M $18M Goddard Enterprises · GreenSky Ventures —
Showing the latest 2 of 4 recorded eventsBook a demo for the full funding history →

Growth signals

Mirexus Biotechnologies website traffic

Latest recorded traffic for Mirexus Biotechnologies is 1.3K monthly website visits, up 766.7% over the last three months. Mirexus Biotechnologies's team grew 0% over the past year.

Latest monthly visits1.3K 3-month web change+766.7% 1-year team growth0%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Investors

3 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed2 investors entered at this stage

  • GreenSky Ventures
  • Goddard Enterprises

Other known investors1 additional known investor

  • University of Guelph
Team profiled 5 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 1 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
🇨🇦 Canada · Guelph HQ
Book a demo for the full country breakdown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Mirexus Biotechnologies on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Mirexus Biotechnologies’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.